Chronic loss of inhibitor-1 diminishes cardiac RyR2 phosphorylation despite exaggerated CaMKII activity

Stefan Neef, Jordi Heijman, Kristian Otte, Matthias Dewenter, Ali R. Saadatmand, Stefanie Meyer-Roxlau, Christopher L. Antos, Johannes Backs, Dobromir Dobrev, Michael Wagner, Lars S. Maier, Ali El-Armouche*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)857-862
Number of pages6
JournalNaunyn-Schmiedebergs Archives of Pharmacology
Volume390
Issue number8
DOIs
Publication statusPublished - Aug 2017

Keywords

  • Inhibitor-1
  • Ca2+/calmodulin-dependent protein kinase II
  • Protein phosphatase 1
  • Ryanodine receptor
  • PROTEIN PHOSPHATASE-1 INHIBITOR-1
  • MYOCARDIAL HYPERTROPHY
  • HEART-FAILURE
  • MYOCYTES

Cite this

Neef, S., Heijman, J., Otte, K., Dewenter, M., Saadatmand, A. R., Meyer-Roxlau, S., Antos, C. L., Backs, J., Dobrev, D., Wagner, M., Maier, L. S., & El-Armouche, A. (2017). Chronic loss of inhibitor-1 diminishes cardiac RyR2 phosphorylation despite exaggerated CaMKII activity. Naunyn-Schmiedebergs Archives of Pharmacology, 390(8), 857-862. https://doi.org/10.1007/s00210-017-1376-1